Large-scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines is a dataset published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0.578, placing it in the top 34% of the data-sharing corpus. It has been cited 10 times, with 10 citing works in its 1-hop citation network.
Ranks in the top 34% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0.218
From 8 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 10 citers.
National Institutes of Health
Grant: 5U01CA168394-04
Biological annotation of TCGA data
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 3P50CA098258-15S1
MD Anderson Gynecologic SPORE for Uterine Cancers
National Institutes of Health
Grant: 5U24CA210949-04
Batch effects in molecular profiling data on cancers: detection, quantitation, interpretation, and correction
National Institutes of Health
Grant: 5U24CA209851-03
TCPA: an Integrated Bioinformatics Resource for Functional Cancer Proteomic Data
National Institutes of Health
Grant: 1P50CA217685-01
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
National Institutes of Health
Grant: 5U24CA210950-04
Integrated analysis of protein expression data from the Reverse Phase Protein Array (RPPA) platform
National Institutes of Health
Grant: 5U24CA143883-02
Integrative Pipeline for Analysis & Translational Application of TCGA Data (GDAC)
Fields of Study
Keywords
Sustainable Development Goals